TSO3 - News Feed http://tso3.com/ TSO3 to Present at the RBC Capital Markets Healthcare Conference Quebec City, Canada and Myrtle Beach, United States, February 14, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced the Company will participate in the RBC Capital Markets Healthcare Conference in New York, New York.  TSO3’s management is scheduled to present on Thursday, February 22, 2018 at 1:35 PM EST. An audio webcast of the Company’s presentation will be available in the investor relations section of TSO3‘s website at www.tso3.com. Replays of the presentation will be available for 90 days. 2018-02-14 10:37:00 http://tso3.com/en/news_events/article/204 TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America Quebec City, Canada and Myrtle Beach, United States, January 25, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”) announced today that, in a joint effort to increase sales to end users and optimize the customer experience, it has entered into a new agreement (the “Sales and Repurchase Agreement”) with Getinge Infection Control AB, its global distribution partner. The Sales and Repurchase Agreement allows the Company to sell its STERIZONE® VP4 Sterilizers and associated products and services directly into the United States and Canada and repurchase not less than 100 STERIZONE® VP4 sterilizers for $3.3 million, with an initial order of 30 units.  Getinge will continue to sell its inventory in North America and the rest of the world and the parties have agreed to a customer selection mechanism to prevent the likelihood of channel conflict. 2018-01-25 10:20:00 http://tso3.com/en/news_events/article/203 TSO3 Provides an Operational Update Quebec City, Canada and Myrtle Beach, United States, – January 25, 2018 – TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company") today provided an update on its 2017 operating activities.    2018-01-25 09:00:00 http://tso3.com/en/news_events/article/202